Casaccia, Marco
Ibatici, Adalberto
Ballerini, Filippo
Barabino, Nicolò Maria
Santoliquido, Matteo
De Cian, Franco
Article History
Received: 23 March 2023
Accepted: 12 August 2023
First Online: 1 September 2023
Declarations
:
: The Italian Drug Agency (AIFA) entity of the Ministry of Health of the Italian Republic has already approved the indication for the use of Indocyanine Green for lymph node diseases. By virtue of this, this retrospective study is non-experimental and therefore does not require approval from our institutional review board (Comitato Etico Ospedale Policlinico san Martino). Informed consent on the procedure and also on the use of the dye was obtained from each patient in the study. The study was carried out according to the relevant guidelines and regulation (Declaration of Helsinki).
: Not applicable.
: Marco Casaccia, Adalberto Ibatici, Filippo Ballerini, Nicol? Maria Barabino, Matteo Santoliquido and Franco De Cian declare that they have no competing interests.